CN109425738B - 猪圆环病毒3型抗体检测试剂盒及其应用 - Google Patents
猪圆环病毒3型抗体检测试剂盒及其应用 Download PDFInfo
- Publication number
- CN109425738B CN109425738B CN201710780753.2A CN201710780753A CN109425738B CN 109425738 B CN109425738 B CN 109425738B CN 201710780753 A CN201710780753 A CN 201710780753A CN 109425738 B CN109425738 B CN 109425738B
- Authority
- CN
- China
- Prior art keywords
- antibody
- porcine circovirus
- circovirus type
- kit
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 110
- 241000202347 Porcine circovirus Species 0.000 title claims abstract description 76
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 60
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 59
- 238000012360 testing method Methods 0.000 claims abstract description 36
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 238000002965 ELISA Methods 0.000 claims abstract description 15
- 238000011161 development Methods 0.000 claims abstract description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 49
- 239000012528 membrane Substances 0.000 claims description 38
- 239000000020 Nitrocellulose Substances 0.000 claims description 27
- 229920001220 nitrocellulos Polymers 0.000 claims description 27
- 238000003908 quality control method Methods 0.000 claims description 26
- 239000011248 coating agent Substances 0.000 claims description 21
- 238000000576 coating method Methods 0.000 claims description 21
- 239000010931 gold Substances 0.000 claims description 20
- 229910052737 gold Inorganic materials 0.000 claims description 20
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 16
- 239000003085 diluting agent Substances 0.000 claims description 16
- 101000582398 Staphylococcus aureus Replication initiation protein Proteins 0.000 claims description 14
- 239000013642 negative control Substances 0.000 claims description 14
- 239000008055 phosphate buffer solution Substances 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000010521 absorption reaction Methods 0.000 claims description 12
- 239000008363 phosphate buffer Substances 0.000 claims description 11
- 239000013641 positive control Substances 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 239000012089 stop solution Substances 0.000 claims description 8
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 239000012154 double-distilled water Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 244000052769 pathogen Species 0.000 abstract description 4
- 239000000523 sample Substances 0.000 description 49
- 235000018102 proteins Nutrition 0.000 description 44
- 210000002966 serum Anatomy 0.000 description 40
- 238000002649 immunization Methods 0.000 description 28
- 241000700605 Viruses Species 0.000 description 26
- 230000003053 immunization Effects 0.000 description 25
- 241000282898 Sus scrofa Species 0.000 description 20
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 238000005507 spraying Methods 0.000 description 12
- 241001533384 Circovirus Species 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 238000007865 diluting Methods 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 241001673669 Porcine circovirus 2 Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- 241000282887 Suidae Species 0.000 description 6
- 206010000210 abortion Diseases 0.000 description 6
- 231100000176 abortion Toxicity 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000001850 reproductive effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 101150044789 Cap gene Proteins 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- -1 Isopropyl- Chemical group 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000928435 Porcine circovirus 1 Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010029164 Nephrotic syndrome Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010009 beating Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000011841 epidemiological investigation Methods 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010006519 Molecular Chaperones Proteins 0.000 description 2
- 102000005431 Molecular Chaperones Human genes 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000013615 primer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101000711919 Staphylococcus aureus Immunoglobulin G-binding protein A Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000012805 animal sample Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710780753.2A CN109425738B (zh) | 2017-09-01 | 2017-09-01 | 猪圆环病毒3型抗体检测试剂盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710780753.2A CN109425738B (zh) | 2017-09-01 | 2017-09-01 | 猪圆环病毒3型抗体检测试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109425738A CN109425738A (zh) | 2019-03-05 |
CN109425738B true CN109425738B (zh) | 2022-01-28 |
Family
ID=65513112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710780753.2A Active CN109425738B (zh) | 2017-09-01 | 2017-09-01 | 猪圆环病毒3型抗体检测试剂盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109425738B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112946262A (zh) * | 2021-01-26 | 2021-06-11 | 石河子大学 | 一种pcv3双抗原夹心elisa抗体检测试剂盒及其应用 |
CN115819567B (zh) * | 2022-11-19 | 2023-09-01 | 深圳盛源生物技术有限公司 | 一种单克隆抗体及其在检测试剂盒中的应用 |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1584597A (zh) * | 2004-06-15 | 2005-02-23 | 浙江大学 | 猪圆环病毒2型抗原或抗体检测elisa试剂盒 |
WO2006093797A2 (en) * | 2005-02-28 | 2006-09-08 | Mj Biologics, Inc. | Method and kit for detecting porcine reproductive and respiratory syndrome virus |
CN101358182A (zh) * | 2007-07-31 | 2009-02-04 | 中国农业科学院哈尔滨兽医研究所 | 表达猪圆环病毒2型Cap蛋白的重组杆状病毒毒株、其构建方法及应用 |
CN101629956A (zh) * | 2009-07-09 | 2010-01-20 | 湖南农业大学 | 检测猪圆环病毒2型抗体的elisa试剂盒 |
CN102329790A (zh) * | 2011-09-28 | 2012-01-25 | 河南省农业科学院 | 双标记核酸恒温扩增方法及检测试纸条 |
CN102735680A (zh) * | 2012-07-05 | 2012-10-17 | 北京大北农科技集团股份有限公司 | 一种猪圆环病毒2型抗体胶体金快速检测试纸条 |
CN102731615A (zh) * | 2011-05-27 | 2012-10-17 | 华威特(北京)生物科技有限公司 | Prrsv的检测试剂和检测方法 |
CN101408548B (zh) * | 2008-11-13 | 2013-07-03 | 浙江大学 | 猪圆环病毒pcv1和pcv2鉴别检测试纸卡 |
CN103255171A (zh) * | 2013-03-07 | 2013-08-21 | 江苏省农业科学院 | 猪圆环病毒2型密码子优化的orf2基因的重组病毒样粒子 |
CN103308688A (zh) * | 2012-03-14 | 2013-09-18 | 武汉中博生物股份有限公司 | 猪圆环病毒2型IgM抗体ELISA检测试剂盒及制备方法 |
CN103698514A (zh) * | 2013-12-17 | 2014-04-02 | 广西大学 | 检测猪胞内劳森氏菌抗体的elisa试剂盒 |
CN103941001A (zh) * | 2013-03-15 | 2014-07-23 | 河南省农业科学院 | 猪副嗜血杆菌快速检测试纸条 |
EP2949341A1 (en) * | 2013-01-25 | 2015-12-02 | Fundacao De Amparo A Pesquisa Do Estado De Minas Gerais - Fapemig | Recombinant antigens of porcine circovirus 2 (pcv-2) for vaccine formulations, diagnostic kit and use thereof |
CN105606802A (zh) * | 2015-12-26 | 2016-05-25 | 哈药集团生物疫苗有限公司 | 同时检测八种猪病相关抗体试剂盒及其使用方法 |
CN105675873A (zh) * | 2016-01-04 | 2016-06-15 | 洛阳普莱柯万泰生物技术有限公司 | 一种检测试剂盒及其应用 |
CN105717293A (zh) * | 2014-12-03 | 2016-06-29 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测猪圆环病毒2型的试剂盒 |
WO2016160761A2 (en) * | 2015-03-30 | 2016-10-06 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 carrier platform |
CN106405082A (zh) * | 2016-08-31 | 2017-02-15 | 洛阳普莱柯万泰生物技术有限公司 | 猪伪狂犬病病毒检测试纸 |
CN108627648A (zh) * | 2017-03-24 | 2018-10-09 | 华南农业大学 | 一种新型猪圆环病毒3型的elisa抗体检测试剂盒及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104017813A (zh) * | 2014-06-03 | 2014-09-03 | 斯澳生物科技(苏州)有限公司 | 截短的pcv2型衣壳蛋白orf2病毒样颗粒及其制备方法 |
CN104725490A (zh) * | 2015-03-23 | 2015-06-24 | 湖北省农业科学院畜牧兽医研究所 | 猪圆环病毒2型elisa抗体检测试剂盒 |
CN106543290A (zh) * | 2016-12-08 | 2017-03-29 | 中崇信诺生物科技泰州有限公司 | 一种重组猪圆环病毒2型Cap蛋白的纯化方法 |
-
2017
- 2017-09-01 CN CN201710780753.2A patent/CN109425738B/zh active Active
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1584597A (zh) * | 2004-06-15 | 2005-02-23 | 浙江大学 | 猪圆环病毒2型抗原或抗体检测elisa试剂盒 |
WO2006093797A2 (en) * | 2005-02-28 | 2006-09-08 | Mj Biologics, Inc. | Method and kit for detecting porcine reproductive and respiratory syndrome virus |
CN101358182A (zh) * | 2007-07-31 | 2009-02-04 | 中国农业科学院哈尔滨兽医研究所 | 表达猪圆环病毒2型Cap蛋白的重组杆状病毒毒株、其构建方法及应用 |
CN101408548B (zh) * | 2008-11-13 | 2013-07-03 | 浙江大学 | 猪圆环病毒pcv1和pcv2鉴别检测试纸卡 |
CN101629956A (zh) * | 2009-07-09 | 2010-01-20 | 湖南农业大学 | 检测猪圆环病毒2型抗体的elisa试剂盒 |
CN102731615A (zh) * | 2011-05-27 | 2012-10-17 | 华威特(北京)生物科技有限公司 | Prrsv的检测试剂和检测方法 |
CN102329790A (zh) * | 2011-09-28 | 2012-01-25 | 河南省农业科学院 | 双标记核酸恒温扩增方法及检测试纸条 |
CN103308688A (zh) * | 2012-03-14 | 2013-09-18 | 武汉中博生物股份有限公司 | 猪圆环病毒2型IgM抗体ELISA检测试剂盒及制备方法 |
CN102735680A (zh) * | 2012-07-05 | 2012-10-17 | 北京大北农科技集团股份有限公司 | 一种猪圆环病毒2型抗体胶体金快速检测试纸条 |
EP2949341A1 (en) * | 2013-01-25 | 2015-12-02 | Fundacao De Amparo A Pesquisa Do Estado De Minas Gerais - Fapemig | Recombinant antigens of porcine circovirus 2 (pcv-2) for vaccine formulations, diagnostic kit and use thereof |
CN103255171A (zh) * | 2013-03-07 | 2013-08-21 | 江苏省农业科学院 | 猪圆环病毒2型密码子优化的orf2基因的重组病毒样粒子 |
CN103941001A (zh) * | 2013-03-15 | 2014-07-23 | 河南省农业科学院 | 猪副嗜血杆菌快速检测试纸条 |
CN103698514A (zh) * | 2013-12-17 | 2014-04-02 | 广西大学 | 检测猪胞内劳森氏菌抗体的elisa试剂盒 |
CN105717293A (zh) * | 2014-12-03 | 2016-06-29 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测猪圆环病毒2型的试剂盒 |
WO2016160761A2 (en) * | 2015-03-30 | 2016-10-06 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 carrier platform |
CN105606802A (zh) * | 2015-12-26 | 2016-05-25 | 哈药集团生物疫苗有限公司 | 同时检测八种猪病相关抗体试剂盒及其使用方法 |
CN105675873A (zh) * | 2016-01-04 | 2016-06-15 | 洛阳普莱柯万泰生物技术有限公司 | 一种检测试剂盒及其应用 |
CN106405082A (zh) * | 2016-08-31 | 2017-02-15 | 洛阳普莱柯万泰生物技术有限公司 | 猪伪狂犬病病毒检测试纸 |
CN108627648A (zh) * | 2017-03-24 | 2018-10-09 | 华南农业大学 | 一种新型猪圆环病毒3型的elisa抗体检测试剂盒及其应用 |
Non-Patent Citations (4)
Title |
---|
"A Novel Porcine Circovirus Distantly Related to Known Circoviruses Is Associated with Porcine Dermatitis and Nephropathy Syndrome and Reproductive Failure";Rachel Palinski 等;《Journal of Virology》;20161026;第91卷(第1期);第1-13页 * |
"Differential Proteome Analysis of Host Cells Infected with Porcine Circovirus Type 2";Xin Zhang 等;《Journal of Proteome Research》;20090827;第8卷(第11期);第5111-5119页 * |
"猪圆环病毒3的流行及应对措施研究";王彩霞 等;《中国兽医杂志》;20170702;第53卷(第7期);第101-104页 * |
"猪圆环病毒-II型抗体检测免疫层析试纸的研制及单克隆抗体的筛选与鉴定";金前跃;《万方数据博士学位论文》;20140225;第34页-第67页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109425738A (zh) | 2019-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111929433B (zh) | 一种非洲猪瘟病毒抗体elisa检测试剂盒及其制备方法 | |
CN110105436B (zh) | 猪圆环病毒3型抗体的elisa检测试剂盒及其制备方法与应用 | |
CN109900902B (zh) | 一种猪伪狂犬病毒gB阻断ELISA抗体检测试剂盒及其应用 | |
KR101848194B1 (ko) | Csfv 항체에 대한 개선된 진단 시험 | |
KR102472939B1 (ko) | 페스티바이러스 | |
CN102731615B (zh) | Prrsv的检测试剂和检测方法 | |
CN110927390A (zh) | 一种检测非洲猪瘟CD2v蛋白抗体的ELISA方法、试剂盒及应用 | |
Huang et al. | Serological profile of torque teno sus virus species 1 (TTSuV1) in pigs and antigenic relationships between two TTSuV1 genotypes (1a and 1b), between two species (TTSuV1 and-2), and between porcine and human anelloviruses | |
CN113009154A (zh) | 一步法新型冠状病毒中和抗体磁性微球检测试剂盒及其应用 | |
CN112724208A (zh) | 一种SADS-CoV重组S蛋白胞外段及其制备方法与应用 | |
CN110964102A (zh) | 能同时与犬、猫、水貂细小病毒结合的单克隆抗体、其可变区序列、杂交瘤细胞株及应用 | |
CN110746495A (zh) | 一种重组蛋白e2及其应用 | |
CN103308688A (zh) | 猪圆环病毒2型IgM抗体ELISA检测试剂盒及制备方法 | |
KR101667122B1 (ko) | 개선된 백신 진단 | |
CN109425738B (zh) | 猪圆环病毒3型抗体检测试剂盒及其应用 | |
CN111474367A (zh) | 非洲猪瘟病毒p30蛋白单克隆抗体筛选和检测用试剂盒及其制备方法 | |
CN105061602A (zh) | 用于检测抗猪产肠毒素性大肠杆菌抗体的融合蛋白、制备方法及应用 | |
CN108918869B (zh) | fiber2蛋白及其重组蛋白在检测血清4型禽腺病毒抗体方面的应用 | |
CN108802368B (zh) | 一种酶联免疫检测牛流产衣原体的试剂盒 | |
CN112125961B (zh) | 牛病毒性腹泻-牛传染性鼻气管炎二联亚单位融合疫苗及其鉴定方法 | |
US20230375548A1 (en) | Indirect enzyme-linked immunosorbent assay detection kit based on p30 protein and p22 protein of african swine fever virus | |
KR20190096965A (ko) | 선천적 진전 a를 야기하는 신규한 페스티바이러스의 단리 | |
CN109900903B (zh) | 一种猪伪狂犬病毒gE阻断ELISA抗体检测试剂盒及其应用 | |
CN111537736A (zh) | 一种鸡毒支原体抗体的间接elisa检测试剂盒及检测方法 | |
CN113388010A (zh) | 新型冠状病毒重组蛋白s1抗原及双抗原夹心elisa抗体检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 471003 No.6 Huaxia Road, high tech Zone, Luoyang area, China (Henan) pilot Free Trade Zone, Luoyang City, Henan Province Applicant after: Luoyang Pu Tai Biotechnology Co.,Ltd. Applicant after: SA BIOTECH (SUZHOU) Pte. Ltd. Address before: 471003 Huaxia Road, hi tech Zone, Luoyang, Henan Applicant before: LUOYANG PULIKE WANTAI BIOLOGICAL TECHNOLOGY CO.,LTD. Applicant before: SA BIOTECH (SUZHOU) Pte. Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 471003 No.6 Huaxia Road, high tech Zone, Luoyang area, China (Henan) pilot Free Trade Zone, Luoyang City, Henan Province Patentee after: Luoyang Pu Tai Biotechnology Co.,Ltd. Country or region after: China Patentee after: Aidi Weixin (Suzhou) Biological Products Co.,Ltd. Address before: 471003 No.6 Huaxia Road, high tech Zone, Luoyang area, China (Henan) pilot Free Trade Zone, Luoyang City, Henan Province Patentee before: Luoyang Pu Tai Biotechnology Co.,Ltd. Country or region before: China Patentee before: SA BIOTECH (SUZHOU) Pte. Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240508 Address after: 471003 No.6 Huaxia Road, high tech Zone, Luoyang area, China (Henan) pilot Free Trade Zone, Luoyang City, Henan Province Patentee after: Luoyang Pu Tai Biotechnology Co.,Ltd. Country or region after: China Patentee after: Sihui Biotechnology (Jiangsu) Co.,Ltd. Address before: 471003 No.6 Huaxia Road, high tech Zone, Luoyang area, China (Henan) pilot Free Trade Zone, Luoyang City, Henan Province Patentee before: Luoyang Pu Tai Biotechnology Co.,Ltd. Country or region before: China Patentee before: Aidi Weixin (Suzhou) Biological Products Co.,Ltd. |